The present invention relates to new pyrido [2,3-d] pyrimidinones and their pharmaceutically acceptable salts. The present invention also relates to compositions comprising a compound according to the present invention, and the use of such compositions in methods of treating diseases and conditions that are successfully treated by administering an inhibitor of CDK-4 and / or CDK-6.
展开▼
